Bio
Experience
-
NewVale Capital
-
Greater Philadelphia
-
Executive Partner
-
2022 - Present
-
Greater Philadelphia
Investment Committee Member
-
-
-
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Chief Executive Officer
-
Mar 2019 - Jan 2021
-
-
Chief Commercial Officer and Head of Business Development
-
Aug 2015 - Feb 2019
Lead all commercial and business development activities globally.
-
Inhibikase Therapeutics, Inc
-
Atlanta, GA and Cambridge, MA
-
Director
-
May 2015 - Dec 2018
-
Atlanta, GA and Cambridge, MA
Independent member of Board of Directors.
-
-
United Kingdom
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
President & CEO Astrazeneca US & Regional Vice President, Americas
-
Nov 2008 - Mar 2013
Accountable for all aspects of business performance in US business, and all other countries in North and South America
-
-
Vice President Brand & Portfolio Operations (Chief Operating Officer)
-
Jan 2006 - Nov 2008
Responsible for commercialization of all brands in the United States in Cardiovascular, Neuroscience, Respiratory, Gastroenterology, Oncology, Pain & Infection Built 3 of the top 5 selling brands in US (Nexium, Crestor and Seroquel) through exceptional sales, marketing and commercial excellence.
-
-
Brand Manager
-
Jan 1993 - Dec 1994
-
-
Sales Representative
-
Jan 1991 - Dec 1992
Sold anti-infectives, vaccines and CV brands.
-
Education
-
1984 - 1987Princeton University
Bachelor of Arts (B.A.), Biology, General -
1990 - 1991University of North Carolina at Chapel Hill
Master of Business Administration (M.B.A.), Business Administration and Management, General
Suggested Services
This profile is unclaimed. These are suggested service rates with 0% commision upon successful connection
Industry Focus. “Biotechnology”
Looking to Create a Custom Project?Get StartedNeed a custom project? We'll create a solution designed specifically for your project.
References
Social Profiles
Community
You need to have a working account to view this content. Click here to join now -